Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

147 Resultados de la búsqueda.
Relevancia Evaluación Nuevo primero Antiguo primero

On-Study - Colorectal Cancer - Advanced On-Study Form - 2282222v3.0 - Colorectal Cancer - Advanced On-Study Form

- 9/1/15 - 1 formulario, 5 itemgroups, 27 items, 1 idioma
Itemgroups: CRF Header, Colorectal: Form Administration, Colorectal: Disease Description, Colorectal: Prior Treatment, Comments
Colorectal Cancer - Advanced On-Study Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DB756AA2-EEA3-2E27-E034-0003BA12F5E7

On-Study - Colorectal Cancer - Adjuvant On-Study Form - 2263800v3.0 - Colorectal Cancer - Adjuvant On-Study Form

- 9/1/15 - 1 formulario, 4 itemgroups, 18 items, 1 idioma
Itemgroups: CRF Header, Colorectal: Form Administration, Colorectal: Disease Characteristics, Comments
Colorectal Cancer - Adjuvant On-Study Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DB75551B-5D8C-2D1C-E034-0003BA12F5E7

CALGB: 80203 On-Study

- 28/7/15 - 1 formulario, 3 itemgroups, 32 items, 1 idioma
Itemgroups: Header, Patient details, CCRR MODULE
CALGB: 80203 On-Study Fluorouracil and Leucovorin Plus Either Irinotecan or Oxaliplatin With or Without Cetuximab in Treating Patients With Previously Untreated Metastatic Adenocarcinoma of the Colon or Rectum Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B4C3AD14-5A1C-0716-E034-0003BA12F5E7

Colorectal Cancer NCT01150045 On-Study - CALGB 80702 On-Study Form - 2970013v1.0 - CALGB 80702 On-Study Form

- 9/1/15 - 1 formulario, 7 itemgroups, 40 items, 1 idioma
Itemgroups: Header Module, Header, PATIENT DESCRIPTION, Surgical Data, Required Lab Values, Cardiac Risk Factors, Footer Module
CALGB 80702 On-Study Form Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7ADB9225-BFE2-FA4C-E040-BB89AD4369EB

Colorectal Cancer NCT01167725 On-Study - USMCI 8214/Z6091: On-Study Form - 2823136v1.0 - USMCI 8214/Z6091: On-Study Form

- 17/9/21 - 1 formulario, 5 itemgroups, 27 items, 1 idioma
Itemgroups: Header Module, Patient Description, Extent of Peritoneal Disease, Pathology Information, Prior Treatment
USMCI 8214/Z6091: On-Study Form Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=60004F3F-C2F6-CADB-E040-BB89AD43053A

E3201 On-Study Form NCT00068692

- 8/7/15 - 1 formulario, 3 itemgroups, 22 items, 1 idioma
Itemgroups: Header, Tumor Staging, CCRR MODULE
E3201 On-Study Form NCT00068692 Comparison of Adjuvant Chemotherapy Regimens in Treating Patients With Stage II or Stage III Rectal Cancer Who Are Receiving Radiation Therapy and Fluorouracil Before or After Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B5520AD5-E6B5-6D17-E034-0003BA12F5E7

E5204 On-Study Form NCT00303628

- 16/6/15 - 1 formulario, 9 itemgroups, 56 items, 1 idioma
Itemgroups: Header, Patient demographics, Baseline Evaluation, Diabetes History, Disease Description, Prior Treatment for this Disease, Prior Surgery for this Disease, Baseline Abnormalities, Comments
E5204 On-Study Form NCT00303628 Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=089B43F4-F7BD-38D3-E044-0003BA3F9857

Colorectal Cancer NCT00058474 On-Study - NSABP PROTOCOL R-04: ON-STUDY FORM - 2086441v3.0 - NSABP PROTOCOL R-04: ON-STUDY FORM

- 9/1/15 - 1 formulario, 2 itemgroups, 17 items, 1 idioma
Itemgroups: CCRR MODULE, Procedure Used to Definitively Stage Primary Tumor
NSABP PROTOCOL R-04: ON-STUDY FORM Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B7ABE8CD-3652-3DD1-E034-0003BA12F5E7

CALGB: 80405 ON-STUDY FORM NCT00265850

- 9/6/15 - 1 formulario, 6 itemgroups, 60 items, 1 idioma
Itemgroups: Header, Patient demographics, PATIENT DESCRIPTION, LAB DATA AT PROTOCOL ENTRY, For patients who consented to the correlative sciences companion study, PRIOR THERAPY DATA
CALGB: 80405 ON-STUDY FORM NCT00265850 Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F39D0458-B14A-5DB0-E034-0003BA3F9857

ECOG 3200 On-Study Form NCT00025337

- 3/6/15 - 1 formulario, 1 itemgroup, 38 items, 1 idioma
Itemgroup: COG On-Study Form
ECOG 3200 On-Study Form NCT00025337 Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A1706D40-4AAF-6AB7-E034-080020C9C0E0

dbGaP phs001193 Hispanic Colorectal Cancer Study - Eligibility

- 1/6/23 - 5 formularios, 1 itemgroup, 3 items, 1 idioma
Itemgroup: IG.elig
Principal Investigator: Jane Figueiredo, PhD, National Institutes of Health, Bethesda, MD, USA MeSH: Colorectal Neoplasms https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001193 Genome-wide association studies (GWAS) of colorectal cancer (CRC) have been instrumental in identifying a number of common susceptibility loci in Non Hispanic (NH)-White populations, and a NCI priority is to extend GWAS findings to other populations to address racial/ethnic disparities in cancer susceptibility. Currently, GWA studies of CRC in NH-Whites, Japanese and African-Americans are ongoing. We propose a complementary study to address this critical research area in Hispanics. Hispanics represent the fastest growing ethnic population in the U.S. and have been largely understudied in terms of genetic susceptibility to cancer. There are noted differences in incidence, survival and mortality in CRC by ethnic/racial groups. Hispanics often present with CRC at a younger age and have a significantly greater incidence of stage IV tumors or metastatic disease compared to NH-Whites. We propose to conduct a large, cost-efficient, population-based GWAS in Hispanics by building upon existing NIH-funded resources, the Colon Cancer Family Registry (Colon CFR) and the Multiethnic Cohort Study (MEC). We plan to recruit 2,500 Hispanic men and women diagnosed with CRC between 01/2008 to present using cancer registries in California, physican referrals and familial referrals. Risk factor/diet questionnaires, pathology reports, Oragene saliva samples (for genotyping), optional blood samples (for genotyping and biometric analysis) and tumor blocks (for MSI testing) will be collected using methodologies developed in the Colon CFR/MEC. Cases of CRC in the MEC (currently 473; anticipated 600 at end) will also be included. Population-based Hispanic individuals without a diagnosis of CRC participating in other GWA studies in the MEC (n=3,900, U01HG004726, Haiman) will be used as controls. We will genotype all 3,100 cases using the Illumina 1M array and use available genotype and epidemiologic data collected on 3,900 controls. Our statistical analyses will include: single-SNP and haplotype effects, gene-environment interactions and heterogeneity by MSI, tumor subtype and family history of CRC. We will replicate findings in a second-stage using CRC cases and controls from Mexico (1,000 cases and 1,000 controls, EU FP7 funding, CHIBCHA, Carvajal-Carmona/Tomlinson). We will also examine heterogeneity of the risk estimates by ethnicity/race by leveraging GWA data on NH-Whites (2,142 cases, 1,909 controls, U01 CA122839, Casey), (4,000 cases, 6,000 NH-White controls, UK-CHIBCHA, Tomlinson), Colombians (2,000 cases and 2,000 controls, CHIBCHA), Japanese (1,000 cases and 1,000 controls) and African-Americans (1,500 cases and 1,500 controls, R01CA126895, Le Marchand). We will genotype replicated significant SNPs in our main and combined analysis in several Hispanic populations (note: studies funded by EU or NIH for data collection but not GWAS), including 800 Puerto Ricans, 2,000 Brazilians, 2,000 Argentineans and 3,000 Spanish/Portuguese, to assess generalizability of findings. We will examine the differences in inflammatory gene transcription dynamics in leukocytes (from blood sample collection) by fatigue level (as assessed from study questionnaire data). This study will have a high impact by addressing the key question of racial/ethnic disparities related to genetic susceptibility to CRC, will provide translational guidelines on biological mechanisms during the cancer survivorship period to increase quality of life among cancer survivors, and will enable further growth and investment into research among Hispanics by providing a resource of genetic data and biospecimens, which is lacking.

pht005973.v1.p1

1 itemgroup 3 items

pht005974.v1.p1

1 itemgroup 3 items

pht005975.v1.p1

1 itemgroup 5 items

pht005976.v1.p1

1 itemgroup 6 items

E5202 Colon Cancer On-Study Form NCT00217737

- 8/7/15 - 1 formulario, 9 itemgroups, 33 items, 1 idioma
Itemgroups: Header, Patient demographics, Data amendment, Baseline Evaluation, Pathologic Staging, CEA, Disease Description, Biological Markers, Comments
E5202 Colon Cancer On-Study Form NCT00217737 Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=EF21AC34-1C36-1B9F-E034-0003BA3F9857

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial